- Who can participate: Eligible participants are adults aged 18-65 diagnosed with Condition X. Participants should not have any other significant health issues and must not be currently participating in another clinical trial.
- Study details: The study involves a randomized, double-blind, placebo-controlled design. Participants will be randomly assigned to receive either the investigational treatment or a placebo. The trial will monitor participants' health over a period of 12 months, with regular assessments to track progress and any potential side effects.